NFKB1 and metabolic dysfunction-associated steatohepatitis: On the other hand, the reduction of the activity of IKB, RelA, and JUN by miR-423-5p may lead to inhibition of the NF-κB pathway, including inactivation of pro-apoptotic factors, thus contributing to the progression of NASH [130].